Actively Recruiting

Age: 18Years +
All Genders
ID05298436

The South London Stroke Register: Improving the Lives of Stroke Survivors With Data

Led by Guy's and St Thomas' NHS Foundation Trust · Updated on 2024-03-06

2000

Participants Needed

7

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are conducting the South London Stroke Register (SLSR), an ongoing observational study tracking stroke patients in a defined area of South London since 1995. The study aims to understand stroke incidence using the updated WHO ICD-11 definition from April 2022, and to examine long-term outcomes for stroke survivors, including mortality, recurrence, daily living activities, quality of life, and mental health. This research supports stroke survivors and stakeholders by providing detailed data on stroke impacts and care over time. The study includes two participant groups: those registered before April 2022 with strokes defined by ICD-10, followed up at 3 months, 1 year, and then at 5, 10, and 15 years; and those registered after April 2022 with strokes defined by ICD-11, followed up at 3 months and annually up to 5 years. Participants complete interviews or questionnaires covering stroke details, cognitive and mental health, and quality of life. No clinical or radiological procedures are performed as part of the study. Participants are identified through hospital and clinic records across eight hospitals serving the study area. Follow-up interviews occur at specified intervals, lasting about 40 minutes and can be done in person, by phone, or by mail. Researchers collect data on stroke outcomes, recurrence, and use of care services. The study runs through December 2026, with ongoing monitoring of stroke incidence, mortality, and functional status using standardized scales. Participants may withdraw at any time without penalty, and the study keeps data confidential and minimizes participant burden.

CONDITIONS

Brief Title

The South London Stroke Register: Improving the Lives of Stroke Survivors With Data

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Confirmed stroke according to WHO ICD-11 clinical definition, including cerebral ischaemic stroke, primary intracerebral haemorrhage, subarachnoid haemorrhage, or stroke not known if ischaemic or haemorrhagic.
  • Living in the study area at the time of the first stroke.
  • First stroke occurring since January 1, 1995 for enrolled participants or since April 1, 2022 for those under the updated definition.
Not Eligible

You will not qualify if you...

  • First ever stroke occurred before January 1, 1995.
  • Main residence at the time of first stroke was outside the study area.
  • Focal neurological signs resolved within 24 hours without CT/MRI evidence of cerebrovascular disease (i.e., transient ischaemic attack).
  • CT/MRI scans positive for cerebrovascular disease but no related neurological deficits (asymptomatic cerebrovascular disease).
  • Brain lesion causing acute symptoms other than stroke, such as cerebral tumour or metastases.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Participants may be identified through hospital and clinic records or scan reports.

Diagnostic Evaluation

Duration - Initial hospital admission period

Participants undergo routine clinical stroke care including MRI and CT scans to confirm stroke diagnosis.

Notification and data collection occur via hospital visits and medical record reviews.

Long-term Monitoring

Duration - Up to 15 years post-stroke depending on cohort

Participants are followed up through interviews to collect information on stroke outcomes, functional status, cognitive function, mental health, and quality of life.

Initial interview followed by interviews at 3 months, 1 year, and then annually up to 5 years for new participants; retrospective cohort includes follow-ups at 5, 10, and 15 years. Interviews may be conducted face-to-face, by telephone, or via postal questionnaire.

Trial Site Locations

Total: 7 locations

1

Barts Health NHS Trust

London, United Kingdom, E1 2ES

Actively Recruiting

2

University College London hospitals NHS Foundation trust

London, United Kingdom, NW1 2PG

Not Yet Recruiting

3

Guy's and St Thomas' NHS Foundation trust

London, United Kingdom, SE1 7EH

Actively Recruiting

4

King's College hospital NHS Foundation Trust

London, United Kingdom, SE5 9RS

Actively Recruiting

5

Chelsea and Westminster Hospital NHS Foundation Trust

London, United Kingdom, Sw10 9NH

Not Yet Recruiting

6

St George's University Hospitals NHS Foundation Trust

London, United Kingdom, SW17 0QT

Actively Recruiting

7

Imperial College Healthcare NHS trust

London, United Kingdom, W2 1BL

Not Yet Recruiting

Loading map...

Research Team

E

Eva S Emmett

M

Matthew O'Connell

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

Pilot Study of 3D Ultrasound Localization Microscopy to Dete...

Subarachnoid Hemorrhage

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here